0001415889-20-001938.txt : 20200720 0001415889-20-001938.hdr.sgml : 20200720 20200720215342 ACCESSION NUMBER: 0001415889-20-001938 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190613 FILED AS OF DATE: 20200720 DATE AS OF CHANGE: 20200720 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pennington James CENTRAL INDEX KEY: 0001668704 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37853 FILM NUMBER: 201037488 MAIL ADDRESS: STREET 1: 25801 INDUSTRIAL BLVD STREET 2: SUITE B CITY: HAYWARD STATE: CA ZIP: 94545 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AzurRx BioPharma, Inc. CENTRAL INDEX KEY: 0001604191 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 760 PARKSIDE AVENUE STREET 2: SUITE 304 CITY: BROOKLYN STATE: NY ZIP: 11226 BUSINESS PHONE: 646-699-7855 MAIL ADDRESS: STREET 1: 760 PARKSIDE AVENUE STREET 2: SUITE 304 CITY: BROOKLYN STATE: NY ZIP: 11226 FORMER COMPANY: FORMER CONFORMED NAME: BioPharma d'Azur, Inc. DATE OF NAME CHANGE: 20140331 4 1 form4-07202020_060734.xml X0306 4 2019-06-13 0001604191 AzurRx BioPharma, Inc. AZRX 0001668704 Pennington James C/O AZURRX BIOPHARMA, INC. 760 PARKSIDE AVE SUITE 304 BROOKLYN NY 11226 false true false false CHIEF MEDICAL OFFICER Stock option (right to buy) 1.75 2019-06-13 4 A 0 110000 0 A 2024-06-12 Common stock, par value $0.0001 per share 110000 110000 D The stock option vests, if at all, upon the achievement of certain specified performance targets. Vesting is conditioned on Mr. Pennington's continued employment by AzurRx BioPharma, Inc. on the applicable vesting date. /s/ James E. Pennington 2020-07-20